VistaGen Therapeutics Inc...

NASDAQ: VTGN · Real-Time Price · USD
3.03
0.07 (2.54%)
At close: Aug 15, 2025, 11:41 AM

VistaGen Therapeutics Revenue

VistaGen Therapeutics reported an annual revenue of $486K, reflecting a -54.32% growth. For the quarter ending June 30, 2025, VistaGen Therapeutics generated $244K in revenue.
Revenue (ttm)
486K
Revenue Growth
-54.32%
Price / Sales Ratio
157.98
Revenue / Employee
10.13K
Employees
48
Market Cap
92.96M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.